<![CDATA[December 2025: Year-End FDA Oncology Actions at a Glance ]]>
December 2025 was a pivotal month in the oncology regulatory arena, defined by approvals actively reshaping the treatment landscape as well as designations spotlighting up-and-coming agents that are poised to make an impact across multiple cancer types. …